Search

"When I first treated, we had no idea how much to give, how often to give... we weren't aware of what the concentration of phage should be." IPATH's Dr. Saima Aslam shares how eight years of treating patients has taught her team to achieve

This month, we explored how Canada's first successful prosthetic joint infection phage therapy case is leading up to a full clinical trial; plus Jessica wrote a guide/manifesto(?) about why you should sequence (and re-sequence) your phages.

"It still doesn't happen overnight — the paperwork itself, I aged like 20 years." Dr. Marisa Azad shares the real timeline and logistics behind Canada's first bone infection phage therapy case, plus why her N-of-1 approach creates a platfor

For this month, we feature a guest post about pipolin use in PCR, two podcasts from Jess, and another lab hacks episode from Jan. Hi everyone, Spring is upon us! Jess has been focused on her research — a slight deviation from phage therapy

"We put a dent in the theory that phage therapy doesn't work. Maybe it does work. Maybe it's worth taking a risk." This week we talk to Jonathan Solomon, CEO of BiomX, about their successful phase 2 clinical trial for diabetic foot osteomye

Roundup time! This month we explored phage therapy at Mayo Clinic with Dr. Gina Suh, Yamini Patel shared her experience at the VoM 2024 Conference in Australia, and Esme Brinsden discussed a new citizen science initiative in South England.

What's it like treating patients with phages at a major US medical center? In a new Podovirus Podcast episode, Mayo Clinic's Dr. Gina Suh shares insights from 5 years of phage therapy — the successes, the challenges, and what it takes to ma

This month, we recap what we learned about phage genome analysis tools, phage production pipelines, n of 1 clinical trials, and more! Happy Summer! I hope everyone’s been enjoying the summer heat that’s apparently been sweeping the country

What are 'n of 1' clinical trials, how do they compare to compassionate use, and how might they be used for phages? This week Jessica shares musings about this topic, which has been swirling in her brain for a while now... Hello everyone! I

Round up time! This month we covered phages and neutrophils, reflected on Phage Directory and Phage Australia, and did our second 'Phage Picks' issue. Hey hey, phellow phantastic phage phans! I’m writing this from our new apartment in Miss

This week, Prof. Urmi Bajpai shares insights (and recordings!) from a phage therapy clinician webinar series she hosted recently, which featured Gina Suh, Chip Schooley, Jon Iredell, Gopal Nath, and Mzia Kutadeladze. At the end of 2023, the

This week, we introduce a new mini-series about building experiments on REDCap, a tool used for collecting clinical patient data. In the first issue, we dive deep into building instruments with nested permutations. I’ve long been fascinated

This week we bring you a guest post from CARB-X, which covers how SNIPR Biome uses CRISPR phages to target E. coli with sharpshooter precision. We were recently invited by CARB-X to re-publish a Spotlight article written by Robin Berghaus

Adam Yang, an intern at Shanghai Institute of Phage, interviewed the co-founder of CreatiPhage, Nannan Wu. CreatiPhage is the first company applying phage therapy to humans in China, and seeks to promote the overall development of phage the

Happy December, everyone. I hope you've all enjoyed your Thanksgiving! Jessica and I took a short break in New Zealand and it was sublime. This past month, we featured an article by Adam Yang that explored COVID-19 and phages. We also featu

This week, Adam Yang of Lake Forest Academy explores secondary bacterial infections behind COVID-19 deaths, and discusses how phage therapy may be used as a solution. ## Summary While most people solely blame the physiological damage and t

Last month Madhav Madurantakam Royam and Jessica Neubauer attended Phage Futures Europe in Amsterdam, and they've brought us a sneak-peek into what they learned! The 6th annual Phage Futures conference was held on the 6th and 7th July 2022

This week Madhav Madurantakam Royam, a PhD student at the University of Warwick, talks to Dr. Alexander Sulakvelidze, founder and CEO of Intralytix, one of the first modern phage companies to have products on the market. This week Madhav Ma

This week, Madhav Madurantakam Royam, a PhD student at the University of Warwick, talks to Dr. Jean-Paul Pirnay about how the Queen Astrid Military Hospital in Belgium is advancing phage therapy. This piece is sponsored by Kisaco Research f

This week, we highlight a new case report published last week in Cell. It documents the successful phage therapy of a Mycobacterium abscessus infection, which led a 26-year old in Colorado with cystic fibrosis to receive a lung transplant o